Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Biology Reports

• Publication date

  2012-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11033-012-1506-2PMID 22297695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.

  2012cited by this paper
• ABC of breast diseases

  2012cited by this paper
• Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer

  2011influential reference
• CYP17, Catechol‐O‐Methyltransferase, and Glutathione Transferase M1 Genetic Polymorphisms, Lifestyle Factors, and Breast Cancer Risk in Women on Prince Edward Island

  2011cited by this paper
• Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study.

  2010cited by this paper
• Association of COMT haplotypes and breast cancer risk in caucasian women.

  2010cited by this paper
• COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studies

  2010influential reference
• Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls

  2010cited by this paper
• Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population

  2010influential reference
• Evaluation of Breast Cancer Risk in a Multigenic Model Including Low Penetrance Genes Involved in Xenobiotic and Estrogen Metabolisms

  2010influential reference
• Genetic Polymorphisms in the Catechol Estrogen Metabolism Pathway and Breast Cancer Risk

  2009influential reference
• BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

  2009cited by this paper
• Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women

  2009cited by this paper
• A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk

  2009cited by this paper
• Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women

  2009cited by this paper
• Assessment of cumulative evidence on genetic associations: interim guidelines.

  2008cited by this paper
• Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

  2008influential reference
• A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives

  2007cited by this paper
• Association between Common Variation in 120 Candidate Genes and Breast Cancer Risk

  2007influential reference
• Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort

  2007influential reference
• Functional polymorphism of thymidylate synthase, but not of the COMT and IL‐1B genes, is associated with breast cancer

  2007cited by this paper
• Age‐specific association of steroid hormone pathway gene polymorphisms with breast cancer risk

  2007influential reference
• Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968 – 2002

  2006cited by this paper
• Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.

  2006influential reference
• SNP-SNP interactions in breast cancer susceptibility

  2006cited by this paper
• Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease

  2006cited by this paper
• Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York

  2006cited by this paper
• Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan.

  2006cited by this paper
• [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].

  2006cited by this paper
• Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis

  2005influential reference
• Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.

  2005cited by this paper
• Estrogen Metabolism–Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study

  2005influential reference
• Estrogen Metabolizing Polymorphisms and Breast Cancer Risk Among Older White Women

  2005influential reference
• Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk

  2005cited by this paper
• Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility

  2005influential reference
• Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

  2005influential reference
• Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.

  2004cited by this paper
• A Family-based Genetic Association Study of Variants in Estrogen-metabolism Genes COMT and CYP1B1 and Breast Cancer Risk

  2004influential reference
• A multigene test for the risk of sporadic breast carcinoma

  2003influential reference
• Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.

  2003influential reference
• Tea intake, COMT genotype, and breast cancer in Asian-American women.

  2003cited by this paper
• [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].

  2003influential reference
• Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population

  2002cited by this paper
• Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

  2002cited by this paper
• Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.

  2002cited by this paper
• A comprehensive review of genetic association studies

  2002cited by this paper
• Polymorphic catechol-O-methyltransferase gene and breast cancer risk.

  2001cited by this paper
• Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women

  2001influential reference
• Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.

  2001cited by this paper
• Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan

  2001influential reference
• COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk.

  2001cited by this paper
• Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.

  2001cited by this paper
• Estimating the world cancer burden: Globocan 2000

  2001cited by this paper
• ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics.

  2000cited by this paper
• A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1

  2000cited by this paper
• Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

  1999influential reference
• A systematic review of genetic polymorphisms and breast cancer risk.

  1999cited by this paper
• Functional role of estrogen metabolism in target cells: review and perspectives.

  1998cited by this paper
• Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.

  1998cited by this paper
• Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.

  1998cited by this paper
• Dual role of catecholoestrogens as hormones and procarcinogens: metabolic activation of oestrogens in the induction of tumours

  1998cited by this paper
• Catechol-O-methyltransferase and breast cancer risk.

  1998cited by this paper
• Meta-analyses of randomised controlled trials.

  1997cited by this paper
• Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens.

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Meta-analyses of randomised controlled trials.

  1997cited by this paper
• An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

  1997influential reference
• Molecular Mechanisms of Estrogen Carcinogenesis

  1996cited by this paper
• Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

  1996cited by this paper
• Medial septal cholinergic neurons express c-Jun but do not undergo DNA fragmentation after fornix-fimbria transections.

  1996cited by this paper
• Molecular mechanisms of estrogen carcinogenesis.

  1996cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• Biogenesis of Catecholestrogens: A Mechanism for Metabolic Activation of Estrogens

  1994cited by this paper
• Meta-analyses of randomized controlled trials.

  1987cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity.

  1979cited by this paper
• Catechol-O-methyl transferase: pharmacological aspects and physiological role.

  1975cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Novel Genetic Susceptibility Markers for Breast Cancer in Iraqi Women: First Evidence of CYP3A4*1B Protective Effects and GSTP1/MTHFR Risk Associations.

  2025cites this paper
• Accurate and sensitive detection of Catechol-O-methyltransferase activity by liquid chromatography with fluorescence detection.

  2020cites this paper
• Proteomics Identification and Validation of Desmocollin‐1 and Catechol‐O‐Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis

  2019cites this paper
• Heterosis in COMT Val158Met Polymorphism Contributes to Sex-Differences in Children’s Math Anxiety

  2019cites this paper
• Methylation of estrogens, obesity and breast cancer

  2018cites this paper
• Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer

  2018cites this paper
• Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia

  2018cites this paper
• The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols

  2017influential citation
• Impact of Catechol-O-Methyltransferase Val 158Met (rs4680) Polymorphism on Breast Cancer Susceptibility in Asian Population

  2017cites this paper
• Associations of endocrine stress‐related gene polymorphisms with risk of autism spectrum disorders: Evidence from an integrated meta‐analysis

  2017cites this paper
• POLYMORPHISMS OF ESTROGEN BIOSYNTHESIS AND METABOLIZING GENES IN EGYPTIAN WOMEN WITH BREAST CANCER.

  2017cites this paper
• Investigation of polymorphisms in genes involved in estrogen metabolism in menstrual migraine.

  2017cites this paper
• Change of COMT Val158Met Genotype in Tumoral B Cells of a Chronic Lymphocytic Leukemia Patient: A Case Report

  2017cites this paper
• Change of COMT Val158Met Genotype in Tumoral B Cells of a Chronic Lymphocytic Leukemia Patient: A Case Report

  2017cites this paper
• Reduced Risk of Cancer in Schizophrenia, a Bridge Toward Etio-Pathology and Therapy of Both Diseases

  2015cites this paper
• association between the cOMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies

  2015cites this paper
• Lack of association between the COMT rs4680 polymorphism and ovarian cancer risk: evidence from a meta-analysis of 3,940 individuals.

  2014cites this paper
• The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis

  2014cites this paper
• Adipose tissue PCB levels and CYP1B1 and COMT genotypes in relation to breast cancer risk in postmenopausal Danish women

  2014cites this paper
• Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator

  2014cites this paper
• Medical Policy Use of Common Genetic Variants to Predict Risk of Nonfamilial Breast Cancer

  2013cites this paper
• Catechol-O-methyltransferase Val158Met polymorphism and risk of autism spectrum disorders

  2013cites this paper
• MMP-2 −1306C > T polymorphism in breast cancer: a case–control study in a South European population

  2013cites this paper
• Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.

  2013cites this paper
• HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case–control study

  2012cites this paper
• Epistasis Analysis for Estrogen Metabolic and Signaling Pathway Genes on Young Ischemic Stroke Patients

  2012cites this paper
• Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.

  2012cites this paper
• HTERT MNS16A polymorphism in breast cancer: a case–control study

  2012cites this paper
• Oncotargets and Therapy Dovepress Dovepress Association between the Comt Val158met Polymorphism and Risk of Cancer: Evidence from 99 Case–control Studies

  year unknowncites this paper